Egros Appointed COO of NovaMedica

Fabrice Egros has been appointed COO, pharmaceutical director and board member of NovaMedica. The business was established as part of the $760 million collaboration between the Russian high technology investment fund RUSNANO and the American health care venture fund Domain Associates.

PeopleNorth AmericaUSBriefs